BioVie (BIVI) filed a shelf registration statement with the US Securities and Exchange Commission Thursday for the potential sale of up to $300 million of securities from time to time in one or more offerings.
The filing covers class A common stock, preferred stock, warrants, debt securities, rights and units.
The company intends to use the net proceeds for general corporate purposes.